Pemetrexed Plus Gemcitabine in Renal Cell Cancer

NCT00491075 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

16

Enrollment

OTHER

Sponsor class

Stopped Closed early for poor accrual.

Conditions

Renal Cell Carcinoma

Interventions

DRUG: Pemetrexed
DRUG: Gemcitabine

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]